Current language:
- HR Hrvatski
The translation of this page has been generated by machine translation.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Machine translations can contain errors potentially reducing clarity and accuracy; the Ombudsman accepts no liability for any discrepancies. For the most reliable information and legal certainty, please refer to the source version in English linked above.
For more information please consult our language and translation policy.
Odgovori Komisije na nalaze Europskog ombudsmana o odbijanju pristupa tekstualnim porukama o cjepivima protiv bolesti COVID-19
News - Date Wednesday | 29 June 2022
Case 1316/2021/MIG - Opened on Thursday | 16 September 2021 - Recommendation on Wednesday | 26 January 2022 - Decision on Tuesday | 12 July 2022 - Institution concerned European Commission ( Maladministration found ) - Country Austria
Komisija je odgovorila na nalaze Ombudsmana o odbijanju da omogući javni pristup tekstualnim porukama između svojeg predsjednika i glavnog izvršnog direktora farmaceutskog poduzeća o ugovoru o cjepivu protiv bolesti COVID-19. U početnoj analizi Ombudsmana navodi se da je odgovor problematičan u nekoliko točaka. Odluka o zatvaranju, koja će biti objavljena u narednim tjednima, uključivat će cjelovitu analizu.